Gender and age differences in systemic lupus erythematosus. A study of 489 greek patients with a review of the literature

Lupus

Volumn 11, Issue 11, 2002, Pages 722-729

  Voulgari, P V ^a   Katsimbri, P ^a   Alamanos, Y ^a   Drosos, A A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Age groups; Gender; Lupus; Men; Men vs women with lupus

Indexed keywords

AUTOANTIBODY; LA ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GREECE; HUMAN; INFLAMMATION; INTERNATIONAL COOPERATION; KIDNEY DISEASE; LABORATORY DIAGNOSIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; LITERATURE; MIDDLE AGED; RETROSPECTIVE STUDY; SEX RATIO; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; GREECE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVIEW LITERATURE; SEX DISTRIBUTION;

EID: 0036442266     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu253oa     Document Type: Article

References (59)

1. Cervera R, Khamashta M, Font J et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Balt) 1993; 72: 113-124.
2. Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: Emerging concepts. Part 2: Dermatologic and joint disease the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995; 123: 42-53.
3. Crinin ME. Musculoskeletal manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am 1988; 14: 99-116.
4. Boumpas DT, Austin HA III, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995; 122: 940-950.
5. Font J, Pallares L, Cervera R et al. Systemic lupus erythematosus in the elderly: Clinical and immunological characteristics. Ann Rheum Dis 1991; 50: 702-705.
6. Ho CT, Mok CC, Lau CS, Wong RW. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998; 57: 437-440.
7. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult-and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 866-872.
8. Wallace DJ. The clinical presentation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus. 5th Edn. William & Wilkins: Baltimore, MD, 1997, pp 627-633.
9. Hochberg MC. Systemic lupus erythematosus. Rheum Dis Clin N Am 1990; 16: 617-639.
10. Yoshida S, Castles JJ, Gershwin ME. The pathogenesis of autoimmunity in New Zeland mice. Semin Arthritis Rheum 1990; 19: 224-242.
11. Carlsten H, Tarkowski A. Histocompatibility complex gene products and exposure to oestrogen: Two independent disease accelerating factors in murine lupus. Scand J Immunol 1993; 38: 341-347.
12. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment, on survival anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978; 147: 1568-1583.
13. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest 1979; 63: 902-911.
14. Buyou JP, Wallace DJ. The endocrine system use of exogenous estrogens and the urogenital tract. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus, 5th Edn. William & Wilkins: Baltimore, MD, 1997, pp 817-834.
15. Chapel TA, Burns RE. Mucosal contraceptives and exacerbation of lupus erythematosus. Am J Obstet Gynecol 1971; 110: 366-369.
16. Furukawa F, Tachibana T, Imamura S, Tamura T. Mucosal contraceptives-induced lupus erythematosus in a Japanese woman. J Dermatol 1991; 18: 56-58.
17. French MA, Hughes P. Systemic lupus erythematosus and Klinefelter's syndrome. Ann Rheum Dis 1983; 42: 471-473.
18. Lavalle C, Loyo E, Paniagua R et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 268-272.
19. Inman RD, Jovanovic L, Markenson JA, Longcope C, Dawood MY, Lockshin MD. Systemic lupus erythematosus in men. Genetic and endocrine features. Arch Intern Med 1982; 142: 1813-1815.
20. Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Balt) 1983; 62: 327-334.
21. Sequeira JF, Keser G, Greenstein B et al. Systemic lupus erythematosus: Sex hormones in male patients. Lupus 1993; 2: 315-317.
22. Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000; 9: 252-257.
23. Jonsson H, Nived O, Sturfelt G. The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol 1988; 15: 505-509.
24. Costallat LT, Coimbra AM. Systemic lupus erythematosus: Clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 1994; 12: 603-607.
25. Hashimoto H, Tsuda H, Hirano T, Takasaki Y, Matsumoto T, Hirose S. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol 1987; 14: 497-501.
26. Domenech I, Aydintug O, Cervera R et al. Systemic lupus erythematosus in 50 year olds. Postgrad Med J 1992; 68: 440-444.
27. Font J, Pallares L, Cervera R et al. Systemic lupus erythematosus in the elderly: Clinical and immunological characteristics. Ann Rheum Dis 1998; 57: 437-440.
28. Maddison PJ. Systemic lupus erythematosus in the elderly. J Rheumatol 1987; 14(Suppl 13): 182-187.
29. Mak SK, Lam EK, Wong AK. Clinical profile of patients with lateonset SLE: Not a benign subgroup. Lupus 1998; 7: 23-28.
30. Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 2000; 9: 96-100.
31. Deesomchok U, Tumrasvin T. Clinical features of systemic lupus erythematosus in Thai males and females. J Med Assoc Thai 1992; 75: 133-139.
32. Hochberg MC, Boyd RE, Ahearn JM et al. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Bait) 1985; 64: 285-295.
33. Sthoeger ZM, Geltner D, Rider A, Bentzich Z. Systemic lupus erythematosus in 49 Israeli males: A retrospective study. Clin Exp Rheumatol 1987; 5: 233-240.
34. Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic PD. Male lupus: Retrospective analysis of the clinical and laboratory features of 52 patients with a review of the literature. Semin Arthritis Rheum 1989; 18: 189-197.
35. Ward MM, Studenski S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990; 17: 220-224.
36. Koh WH, Fong KY, Boey ML, Feng PH. Systemic lupus erythematosus in 61 Oriental males. A study of clinical and laboratory manifestations. Br J Rheumatol 1994; 33: 339-342.
37. Pande I, Malaviya AN, Sekharan NG, Kailash S, Uppal SS, Kumar A. SLE in Indian men: Analysis of the clinical and laboratory features with a review of the literature. Lupus 1994; 3: 181-186.
38. Molina JF, Drenkard C, Molina J et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Balt) 1996; 75: 124-130.
39. Specker C, Becker A, Lakomek HJ, Bach D, Grabensee B. Systemic lupus erythematosus in men - A different prognosis? J Rheumatol 1994; 53: 339-345.
40. Mok CC, Lau CS, Chan TM, Wong RW. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999; 8: 188-196.
41. Font J, Cervera R, Navarro M et al. Systemic lupus erythematosus in men: Clinical and immunological characteristics. Ann Rheum Dis 1992; 51: 1050-1052.
42. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
43. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-547.
44. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
45. Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML. The clinical features and prognosis of male lupus in Taiwan. Lupus 1998; 7: 462-468.
46. Keskin G, Tokgöz G, Düzgün N et al. Systemic lupus erythematosus in Turkish men. Exp Rheum 2000; 18: 114-115.
47. Alballa SR. Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 1995; 14: 342-346.
48. al-Attia HM, George S. Characterization of systemic lupus erythematosus in patients in UAE. Clin Rheumatol 1995; 14: 171-175.
49. Uthman I, Nasr F, Kassak K, Masri AF. Systemic lupus erythematosus in Lebanon. Lupus 1999; 8: 713-715.
50. Vila LM, Mayor AM, Valentin AH, Garcia-Soberal M, Vila S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999; 8: 279-286.
51. Lee SS, Li CS, Li PC. Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993; 2: 105-109.
52. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: A descriptive analysis of 292 patients. Lupus 1993; 2: 303-312.
53. Shaikh SK, Wang F. Late-onset systemic lupus erythematosus: Clinical and immunological characteristics. Med J Malaysia 1995; 50: 25-31.
54. Blanco FJ, de la Mata J, Gomez-Reino JJ et al. Clinical and serological manifestations of 307 Spanish patients with systemic lupus erythematosus. Comparison with other ethnic groups. Rev Clin Esp 1995; 195: 534-540.
55. Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus: Differences related to race and age of onset. Arthritis Rheum 1982; 25: 55-60.
56. Petri M. Hopkins Lupus Cohort 1999 update. Rheum Dis Clin N Am 2000; 26: 199-213.
57. Swaak AJ, van den Brink HG, Smeenk RJ et al. Systemic lupus erythematosus: Clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxf) 1999; 38: 953-958.
58. Zonana-Nacach A, Camargo-Coronel A, Yanez P et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: Relationship with disease duration. Lupus 1998; 7: 119-123.
59. Rivest C, Lew RA, Welsing PM et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000; 27: 680-684.